Literature DB >> 2344657

Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.

U F Schade1.   

Abstract

Pentoxifylline (POF) was found to possess high protecting potential in murine endotoxin shock. POF was tested in endotoxic shock in normal, LPS-tolerant, LPS-hyperreactive, and D-galactosamine-sensitized mice. A dose of 50 mg/kg increased survival in normal and tolerant mice from 50% in LPS-controls to 90%, and in LPS-hypersensitized and D-galactosamine-sensitized mice from 20% in LPS-controls to 90%. POF did not interfere with the development of endotoxin tolerance. The protective effects of POF were dose-dependent and were observed, even when POF was given up to 4 h post endotoxin. POF was found to inhibit the appearance of TNF in serum of LPS-treated, D-galactosamine-sensitized mice and in the supernatants of LPS-stimulated, thioglycollate-induced mouse peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344657

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  20 in total

1.  Liver: Can pentoxifylline secure its place in liver therapeutics?

Authors:  Stuart F W Kendrick; Chris P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11       Impact factor: 46.802

2.  Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.

Authors:  M J Edwards; B T Heniford; E A Klar; K W Doak; F N Miller
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock.

Authors:  T Staudinger; E Presterl; W Graninger; G J Locker; S Knapp; K Laczika; G Klappacher; B Stoiser; A Wagner; P Tesinsky; H Kordova; M Frass
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

4.  Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Santanu Kar Mahapatra; Satyajit Tripathy; Totan Ghosh; Balaram Das; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2014-01-21       Impact factor: 3.358

5.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Totan Ghosh; Sabyasachi Das; Satyajit Tripathy; Debasis Mandal; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2013-09-17       Impact factor: 3.358

7.  Pentoxifylline pretreatment fails to block the acute-phase response to Escherichia coli endotoxin in dwarf goats.

Authors:  C T Van Duin; T Wensing; A S Van Miert
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

8.  Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.

Authors:  D F Eierman; M Yagami; S M Erme; S R Minchey; P A Harmon; K J Pratt; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?

Authors:  J Boldt; M Müller; M Heesen; S Heyn; G Hempelmann
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

10.  Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.

Authors:  C Thiemermann; C C Wu; C Szabó; M Perretti; J R Vane
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.